Skip to main content
. 2020 May 18;20:430. doi: 10.1186/s12885-020-06940-z

Fig. 2.

Fig. 2

Survival outcomes according to newly defined cutoff points for ER and PR expression in ER+/HER2– IBC and corresponding non-IBC. a Distant disease-free survival by ER and PR levels for non-IBC. b Distant disease-free survival by ER and PR levels for IBC c Overall survival by ER and PR levels for non-IBC. d Overall survival by ER and PR levels for IBC